Ping An Insurance has raised almost $1bn in funding for its medical data analysis unit ahead of an initial public offering for the business, with investors including the SoftBank Vision Fund.

Qualcomm-backed physical performance analysis platform Sparta Science has raised series A funds as it looks to expand from sports into clinical health.

Celgene has agreed to acquire Impact Biomedicines for a multibillion dollar whose total size may reach $7bn, giving an exit to fellow pharmaceutical company Sanofi. This is a record-setting deal in the life-sciences exits involving corporate investors, where other transactions like IPOs seems to have been in decline.

The paediatric care platform has now raised more than $29m in total, closing a Wanxiang-backed round co-led by an affiliate of Access Industries.

Via Oncology has been acquired by Elsevier for an undisclosed amount, nine years after being spun out of UPMC.

Humboldt University of Berlin spinout Newsenselab has lured High-Tech Gründerfonds and Think.Health Ventures back to the table after an earlier six-figure round in November 2016.

The University of Utah spinout is using deep learning technology to power image analysis in pathology.

The corporate-backed cancer drug developer is reportedly valued at $1bn and is eyeing an initial public offering that could raise up to $200m.